// App-Quantinova.ai

: Combination of BCR-ABL1 Tyrosine Kinase Inhibitors with a Small Molecule LIM kinase1/2 Inhibitor in BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

Researchers

Presenter

  • Thorsten Braun

Principal Investigators

  • Jeannig Berrou

  • Renaud Prudent

  • Hanane Djamai

  • Melanie Dupont

  • Anna Kaci

  • Emilie Adiceam

  • Fabrice Paublant

  • Andre Baruchel

  • Jacques Ghysdael

  • Claude Gardin

  • Herve Dombret

Medical Centers

  • IUH, EA3518 Leukemia Translational Laboratory, Paris, France

  • CELLIPSE Company, Grenoble, France

  • Institut Curie, UMR 3348 AMOR-GUERET, Orsay, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 34

Drug/Treatment

  • Nilotinib

  • Ponatinib

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved